Symrise Group
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Determination of Biological Activity of Human-enriched Serum Following Chondractiv™ Plus Ingredient Ingestion (NCT06800820) | Symrise Group | 2025-01-23 |
| Chondractiv Move on Activity-related Joint Discomfort (NCT06714851) | Symrise Group | 2024-11-25 |
Track Symrise Group automatically
Every clearance here is in the API, with alerts when new ones post.